Global Cell Therapy and Tissue Engineering Supply, Demand and Key Producers, 2023-2029
Page: 126
Published Date: 19 Jan 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
This report studies the global Cell Therapy and Tissue Engineering demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy and Tissue Engineering, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy and Tissue Engineering that contribute to its increasing demand across many markets.
The global Cell Therapy and Tissue Engineering market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
Highlights and key features of the study
Global Cell Therapy and Tissue Engineering total market, 2018-2029, (USD Million)
Global Cell Therapy and Tissue Engineering total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell Therapy and Tissue Engineering total market, key domestic companies and share, (USD Million)
Global Cell Therapy and Tissue Engineering revenue by player and market share 2018-2023, (USD Million)
Global Cell Therapy and Tissue Engineering total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell Therapy and Tissue Engineering total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell Therapy and Tissue Engineering market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Betalin Therapeutics, BioCardia, Inc, BioReliance Corporation, Biosolution Co., Brainstorm Cell Therapeutics, Inc, MaxCyte, Inc, Medigene AG, MEDIPOST CO. and Mesoblast Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy and Tissue Engineering market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell Therapy and Tissue Engineering Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Cell Therapy and Tissue Engineering Market, Segmentation by Type
Cell Therapy
Tissue Engineering
Global Cell Therapy and Tissue Engineering Market, Segmentation by Application
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
Companies Profiled:
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Key Questions Answered
1. How big is the global Cell Therapy and Tissue Engineering market?
2. What is the demand of the global Cell Therapy and Tissue Engineering market?
3. What is the year over year growth of the global Cell Therapy and Tissue Engineering market?
4. What is the total value of the global Cell Therapy and Tissue Engineering market?
5. Who are the major players in the global Cell Therapy and Tissue Engineering market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Cell Therapy and Tissue Engineering Introduction
1.2 World Cell Therapy and Tissue Engineering Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell Therapy and Tissue Engineering Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy and Tissue Engineering Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.3 China Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.4 Europe Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.5 Japan Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.6 South Korea Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.7 ASEAN Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.3.8 India Cell Therapy and Tissue Engineering Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy and Tissue Engineering Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy and Tissue Engineering Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.2 World Cell Therapy and Tissue Engineering Consumption Value by Region
2.2.1 World Cell Therapy and Tissue Engineering Consumption Value by Region (2018-2023)
2.2.2 World Cell Therapy and Tissue Engineering Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.4 China Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.5 Europe Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.6 Japan Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.7 South Korea Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.8 ASEAN Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
2.9 India Cell Therapy and Tissue Engineering Consumption Value (2018-2029)
3.1 World Cell Therapy and Tissue Engineering Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy and Tissue Engineering Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy and Tissue Engineering in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy and Tissue Engineering in 2022
3.3 Cell Therapy and Tissue Engineering Company Evaluation Quadrant
3.4 Cell Therapy and Tissue Engineering Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy and Tissue Engineering Market: Region Footprint
3.4.2 Cell Therapy and Tissue Engineering Market: Company Product Type Footprint
3.4.3 Cell Therapy and Tissue Engineering Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: Cell Therapy and Tissue Engineering Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy and Tissue Engineering Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy and Tissue Engineering Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell Therapy and Tissue Engineering Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy and Tissue Engineering Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy and Tissue Engineering Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell Therapy and Tissue Engineering Companies and Market Share, 2018-2023
4.3.1 United States Based Cell Therapy and Tissue Engineering Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023)
4.4 China Based Companies Cell Therapy and Tissue Engineering Revenue and Market Share, 2018-2023
4.4.1 China Based Cell Therapy and Tissue Engineering Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023)
4.5 Rest of World Based Cell Therapy and Tissue Engineering Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell Therapy and Tissue Engineering Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023)
5.1 World Cell Therapy and Tissue Engineering Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Tissue Engineering
5.3 Market Segment by Type
5.3.1 World Cell Therapy and Tissue Engineering Market Size by Type (2018-2023)
5.3.2 World Cell Therapy and Tissue Engineering Market Size by Type (2024-2029)
5.3.3 World Cell Therapy and Tissue Engineering Market Size Market Share by Type (2018-2029)
6.1 World Cell Therapy and Tissue Engineering Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cell Defects
6.2.2 Genetic Diseases
6.2.3 Neurodegenerative Diseases
6.2.4 Tissue Malignancies
6.2.5 Tissue Malignancies
6.3 Market Segment by Application
6.3.1 World Cell Therapy and Tissue Engineering Market Size by Application (2018-2023)
6.3.2 World Cell Therapy and Tissue Engineering Market Size by Application (2024-2029)
6.3.3 World Cell Therapy and Tissue Engineering Market Size by Application (2018-2029)
7.1 Betalin Therapeutics
7.1.1 Betalin Therapeutics Details
7.1.2 Betalin Therapeutics Major Business
7.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Product and Services
7.1.4 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Betalin Therapeutics Recent Developments/Updates
7.1.6 Betalin Therapeutics Competitive Strengths & Weaknesses
7.2 BioCardia, Inc
7.2.1 BioCardia, Inc Details
7.2.2 BioCardia, Inc Major Business
7.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Product and Services
7.2.4 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 BioCardia, Inc Recent Developments/Updates
7.2.6 BioCardia, Inc Competitive Strengths & Weaknesses
7.3 BioReliance Corporation
7.3.1 BioReliance Corporation Details
7.3.2 BioReliance Corporation Major Business
7.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Product and Services
7.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioReliance Corporation Recent Developments/Updates
7.3.6 BioReliance Corporation Competitive Strengths & Weaknesses
7.4 Biosolution Co.
7.4.1 Biosolution Co. Details
7.4.2 Biosolution Co. Major Business
7.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Product and Services
7.4.4 Biosolution Co. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Biosolution Co. Recent Developments/Updates
7.4.6 Biosolution Co. Competitive Strengths & Weaknesses
7.5 Brainstorm Cell Therapeutics, Inc
7.5.1 Brainstorm Cell Therapeutics, Inc Details
7.5.2 Brainstorm Cell Therapeutics, Inc Major Business
7.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
7.5.4 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Brainstorm Cell Therapeutics, Inc Recent Developments/Updates
7.5.6 Brainstorm Cell Therapeutics, Inc Competitive Strengths & Weaknesses
7.6 MaxCyte, Inc
7.6.1 MaxCyte, Inc Details
7.6.2 MaxCyte, Inc Major Business
7.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Product and Services
7.6.4 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 MaxCyte, Inc Recent Developments/Updates
7.6.6 MaxCyte, Inc Competitive Strengths & Weaknesses
7.7 Medigene AG
7.7.1 Medigene AG Details
7.7.2 Medigene AG Major Business
7.7.3 Medigene AG Cell Therapy and Tissue Engineering Product and Services
7.7.4 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Medigene AG Recent Developments/Updates
7.7.6 Medigene AG Competitive Strengths & Weaknesses
7.8 MEDIPOST CO.
7.8.1 MEDIPOST CO. Details
7.8.2 MEDIPOST CO. Major Business
7.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Product and Services
7.8.4 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 MEDIPOST CO. Recent Developments/Updates
7.8.6 MEDIPOST CO. Competitive Strengths & Weaknesses
7.9 Mesoblast Limited
7.9.1 Mesoblast Limited Details
7.9.2 Mesoblast Limited Major Business
7.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Product and Services
7.9.4 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Mesoblast Limited Recent Developments/Updates
7.9.6 Mesoblast Limited Competitive Strengths & Weaknesses
7.10 Miromatrix Medical, Inc.
7.10.1 Miromatrix Medical, Inc. Details
7.10.2 Miromatrix Medical, Inc. Major Business
7.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product and Services
7.10.4 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Miromatrix Medical, Inc. Recent Developments/Updates
7.10.6 Miromatrix Medical, Inc. Competitive Strengths & Weaknesses
7.11 MolMed S.p.A
7.11.1 MolMed S.p.A Details
7.11.2 MolMed S.p.A Major Business
7.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Product and Services
7.11.4 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 MolMed S.p.A Recent Developments/Updates
7.11.6 MolMed S.p.A Competitive Strengths & Weaknesses
7.12 Mustang Bio, Inc
7.12.1 Mustang Bio, Inc Details
7.12.2 Mustang Bio, Inc Major Business
7.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Product and Services
7.12.4 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Mustang Bio, Inc Recent Developments/Updates
7.12.6 Mustang Bio, Inc Competitive Strengths & Weaknesses
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Details
7.13.2 NantKwest, Inc. Major Business
7.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Product and Services
7.13.4 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 NantKwest, Inc. Recent Developments/Updates
7.13.6 NantKwest, Inc. Competitive Strengths & Weaknesses
7.14 Neuralstem, Inc
7.14.1 Neuralstem, Inc Details
7.14.2 Neuralstem, Inc Major Business
7.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Product and Services
7.14.4 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Neuralstem, Inc Recent Developments/Updates
7.14.6 Neuralstem, Inc Competitive Strengths & Weaknesses
7.15 NexImmune, Inc.
7.15.1 NexImmune, Inc. Details
7.15.2 NexImmune, Inc. Major Business
7.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Product and Services
7.15.4 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 NexImmune, Inc. Recent Developments/Updates
7.15.6 NexImmune, Inc. Competitive Strengths & Weaknesses
7.16 Nohla Therapeutics, Inc
7.16.1 Nohla Therapeutics, Inc Details
7.16.2 Nohla Therapeutics, Inc Major Business
7.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
7.16.4 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Nohla Therapeutics, Inc Recent Developments/Updates
7.16.6 Nohla Therapeutics, Inc Competitive Strengths & Weaknesses
7.17 ReNeuron Group plc
7.17.1 ReNeuron Group plc Details
7.17.2 ReNeuron Group plc Major Business
7.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Services
7.17.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 ReNeuron Group plc Recent Developments/Updates
7.17.6 ReNeuron Group plc Competitive Strengths & Weaknesses
7.18 Richter-Helm BioLogics GmbH & Co. KG
7.18.1 Richter-Helm BioLogics GmbH & Co. KG Details
7.18.2 Richter-Helm BioLogics GmbH & Co. KG Major Business
7.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product and Services
7.18.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments/Updates
7.18.6 Richter-Helm BioLogics GmbH & Co. KG Competitive Strengths & Weaknesses
7.19 RoosterBio, Inc
7.19.1 RoosterBio, Inc Details
7.19.2 RoosterBio, Inc Major Business
7.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Product and Services
7.19.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 RoosterBio, Inc Recent Developments/Updates
7.19.6 RoosterBio, Inc Competitive Strengths & Weaknesses
7.20 RoslinCT
7.20.1 RoslinCT Details
7.20.2 RoslinCT Major Business
7.20.3 RoslinCT Cell Therapy and Tissue Engineering Product and Services
7.20.4 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 RoslinCT Recent Developments/Updates
7.20.6 RoslinCT Competitive Strengths & Weaknesses
7.21 Rubius Therapeutics, Inc.
7.21.1 Rubius Therapeutics, Inc. Details
7.21.2 Rubius Therapeutics, Inc. Major Business
7.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product and Services
7.21.4 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Rubius Therapeutics, Inc. Recent Developments/Updates
7.21.6 Rubius Therapeutics, Inc. Competitive Strengths & Weaknesses
7.22 Sangamo Therapeutics, Inc
7.22.1 Sangamo Therapeutics, Inc Details
7.22.2 Sangamo Therapeutics, Inc Major Business
7.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
7.22.4 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 Sangamo Therapeutics, Inc Recent Developments/Updates
7.22.6 Sangamo Therapeutics, Inc Competitive Strengths & Weaknesses
7.23 Voyager Therapeutics, Inc
7.23.1 Voyager Therapeutics, Inc Details
7.23.2 Voyager Therapeutics, Inc Major Business
7.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
7.23.4 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Voyager Therapeutics, Inc Recent Developments/Updates
7.23.6 Voyager Therapeutics, Inc Competitive Strengths & Weaknesses
7.24 Waisman Biomanufacturing
7.24.1 Waisman Biomanufacturing Details
7.24.2 Waisman Biomanufacturing Major Business
7.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Services
7.24.4 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Waisman Biomanufacturing Recent Developments/Updates
7.24.6 Waisman Biomanufacturing Competitive Strengths & Weaknesses
7.25 WindMIL Therapeutics, Inc.
7.25.1 WindMIL Therapeutics, Inc. Details
7.25.2 WindMIL Therapeutics, Inc. Major Business
7.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product and Services
7.25.4 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 WindMIL Therapeutics, Inc. Recent Developments/Updates
7.25.6 WindMIL Therapeutics, Inc. Competitive Strengths & Weaknesses
7.26 Wuxi App Tec, Inc.
7.26.1 Wuxi App Tec, Inc. Details
7.26.2 Wuxi App Tec, Inc. Major Business
7.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product and Services
7.26.4 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Wuxi App Tec, Inc. Recent Developments/Updates
7.26.6 Wuxi App Tec, Inc. Competitive Strengths & Weaknesses
7.27 ReNeuron Group plc
7.27.1 ReNeuron Group plc Details
7.27.2 ReNeuron Group plc Major Business
7.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Services
7.27.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 ReNeuron Group plc Recent Developments/Updates
7.27.6 ReNeuron Group plc Competitive Strengths & Weaknesses
7.28 Richter-Helm BioLogics GmbH & Co. KG
7.28.1 Richter-Helm BioLogics GmbH & Co. KG Details
7.28.2 Richter-Helm BioLogics GmbH & Co. KG Major Business
7.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product and Services
7.28.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments/Updates
7.28.6 Richter-Helm BioLogics GmbH & Co. KG Competitive Strengths & Weaknesses
7.29 RoosterBio, Inc
7.29.1 RoosterBio, Inc Details
7.29.2 RoosterBio, Inc Major Business
7.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Product and Services
7.29.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 RoosterBio, Inc Recent Developments/Updates
7.29.6 RoosterBio, Inc Competitive Strengths & Weaknesses
7.30 RoslinCT
7.30.1 RoslinCT Details
7.30.2 RoslinCT Major Business
7.30.3 RoslinCT Cell Therapy and Tissue Engineering Product and Services
7.30.4 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 RoslinCT Recent Developments/Updates
7.30.6 RoslinCT Competitive Strengths & Weaknesses
8.1 Cell Therapy and Tissue Engineering Industry Chain
8.2 Cell Therapy and Tissue Engineering Upstream Analysis
8.3 Cell Therapy and Tissue Engineering Midstream Analysis
8.4 Cell Therapy and Tissue Engineering Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Cell Therapy and Tissue Engineering Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy and Tissue Engineering Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy and Tissue Engineering Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy and Tissue Engineering Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell Therapy and Tissue Engineering Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy and Tissue Engineering Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell Therapy and Tissue Engineering Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell Therapy and Tissue Engineering Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell Therapy and Tissue Engineering Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy and Tissue Engineering Players in 2022
Table 12. World Cell Therapy and Tissue Engineering Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell Therapy and Tissue Engineering Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy and Tissue Engineering Player
Table 15. Cell Therapy and Tissue Engineering Market: Company Product Type Footprint
Table 16. Cell Therapy and Tissue Engineering Market: Company Product Application Footprint
Table 17. Cell Therapy and Tissue Engineering Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy and Tissue Engineering Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell Therapy and Tissue Engineering Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell Therapy and Tissue Engineering Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell Therapy and Tissue Engineering Revenue Market Share (2018-2023)
Table 23. China Based Cell Therapy and Tissue Engineering Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell Therapy and Tissue Engineering Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell Therapy and Tissue Engineering Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell Therapy and Tissue Engineering Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy and Tissue Engineering Revenue Market Share (2018-2023)
Table 29. World Cell Therapy and Tissue Engineering Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell Therapy and Tissue Engineering Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell Therapy and Tissue Engineering Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell Therapy and Tissue Engineering Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell Therapy and Tissue Engineering Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell Therapy and Tissue Engineering Market Size by Application (2024-2029) & (USD Million)
Table 35. Betalin Therapeutics Basic Information, Area Served and Competitors
Table 36. Betalin Therapeutics Major Business
Table 37. Betalin Therapeutics Cell Therapy and Tissue Engineering Product and Services
Table 38. Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Betalin Therapeutics Recent Developments/Updates
Table 40. Betalin Therapeutics Competitive Strengths & Weaknesses
Table 41. BioCardia, Inc Basic Information, Area Served and Competitors
Table 42. BioCardia, Inc Major Business
Table 43. BioCardia, Inc Cell Therapy and Tissue Engineering Product and Services
Table 44. BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. BioCardia, Inc Recent Developments/Updates
Table 46. BioCardia, Inc Competitive Strengths & Weaknesses
Table 47. BioReliance Corporation Basic Information, Area Served and Competitors
Table 48. BioReliance Corporation Major Business
Table 49. BioReliance Corporation Cell Therapy and Tissue Engineering Product and Services
Table 50. BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioReliance Corporation Recent Developments/Updates
Table 52. BioReliance Corporation Competitive Strengths & Weaknesses
Table 53. Biosolution Co. Basic Information, Area Served and Competitors
Table 54. Biosolution Co. Major Business
Table 55. Biosolution Co. Cell Therapy and Tissue Engineering Product and Services
Table 56. Biosolution Co. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Biosolution Co. Recent Developments/Updates
Table 58. Biosolution Co. Competitive Strengths & Weaknesses
Table 59. Brainstorm Cell Therapeutics, Inc Basic Information, Area Served and Competitors
Table 60. Brainstorm Cell Therapeutics, Inc Major Business
Table 61. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
Table 62. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Brainstorm Cell Therapeutics, Inc Recent Developments/Updates
Table 64. Brainstorm Cell Therapeutics, Inc Competitive Strengths & Weaknesses
Table 65. MaxCyte, Inc Basic Information, Area Served and Competitors
Table 66. MaxCyte, Inc Major Business
Table 67. MaxCyte, Inc Cell Therapy and Tissue Engineering Product and Services
Table 68. MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. MaxCyte, Inc Recent Developments/Updates
Table 70. MaxCyte, Inc Competitive Strengths & Weaknesses
Table 71. Medigene AG Basic Information, Area Served and Competitors
Table 72. Medigene AG Major Business
Table 73. Medigene AG Cell Therapy and Tissue Engineering Product and Services
Table 74. Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Medigene AG Recent Developments/Updates
Table 76. Medigene AG Competitive Strengths & Weaknesses
Table 77. MEDIPOST CO. Basic Information, Area Served and Competitors
Table 78. MEDIPOST CO. Major Business
Table 79. MEDIPOST CO. Cell Therapy and Tissue Engineering Product and Services
Table 80. MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. MEDIPOST CO. Recent Developments/Updates
Table 82. MEDIPOST CO. Competitive Strengths & Weaknesses
Table 83. Mesoblast Limited Basic Information, Area Served and Competitors
Table 84. Mesoblast Limited Major Business
Table 85. Mesoblast Limited Cell Therapy and Tissue Engineering Product and Services
Table 86. Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Mesoblast Limited Recent Developments/Updates
Table 88. Mesoblast Limited Competitive Strengths & Weaknesses
Table 89. Miromatrix Medical, Inc. Basic Information, Area Served and Competitors
Table 90. Miromatrix Medical, Inc. Major Business
Table 91. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 92. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Miromatrix Medical, Inc. Recent Developments/Updates
Table 94. Miromatrix Medical, Inc. Competitive Strengths & Weaknesses
Table 95. MolMed S.p.A Basic Information, Area Served and Competitors
Table 96. MolMed S.p.A Major Business
Table 97. MolMed S.p.A Cell Therapy and Tissue Engineering Product and Services
Table 98. MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. MolMed S.p.A Recent Developments/Updates
Table 100. MolMed S.p.A Competitive Strengths & Weaknesses
Table 101. Mustang Bio, Inc Basic Information, Area Served and Competitors
Table 102. Mustang Bio, Inc Major Business
Table 103. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product and Services
Table 104. Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Mustang Bio, Inc Recent Developments/Updates
Table 106. Mustang Bio, Inc Competitive Strengths & Weaknesses
Table 107. NantKwest, Inc. Basic Information, Area Served and Competitors
Table 108. NantKwest, Inc. Major Business
Table 109. NantKwest, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 110. NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. NantKwest, Inc. Recent Developments/Updates
Table 112. NantKwest, Inc. Competitive Strengths & Weaknesses
Table 113. Neuralstem, Inc Basic Information, Area Served and Competitors
Table 114. Neuralstem, Inc Major Business
Table 115. Neuralstem, Inc Cell Therapy and Tissue Engineering Product and Services
Table 116. Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Neuralstem, Inc Recent Developments/Updates
Table 118. Neuralstem, Inc Competitive Strengths & Weaknesses
Table 119. NexImmune, Inc. Basic Information, Area Served and Competitors
Table 120. NexImmune, Inc. Major Business
Table 121. NexImmune, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 122. NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. NexImmune, Inc. Recent Developments/Updates
Table 124. NexImmune, Inc. Competitive Strengths & Weaknesses
Table 125. Nohla Therapeutics, Inc Basic Information, Area Served and Competitors
Table 126. Nohla Therapeutics, Inc Major Business
Table 127. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
Table 128. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Nohla Therapeutics, Inc Recent Developments/Updates
Table 130. Nohla Therapeutics, Inc Competitive Strengths & Weaknesses
Table 131. ReNeuron Group plc Basic Information, Area Served and Competitors
Table 132. ReNeuron Group plc Major Business
Table 133. ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Services
Table 134. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. ReNeuron Group plc Recent Developments/Updates
Table 136. ReNeuron Group plc Competitive Strengths & Weaknesses
Table 137. Richter-Helm BioLogics GmbH & Co. KG Basic Information, Area Served and Competitors
Table 138. Richter-Helm BioLogics GmbH & Co. KG Major Business
Table 139. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product and Services
Table 140. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Richter-Helm BioLogics GmbH & Co. KG Recent Developments/Updates
Table 142. Richter-Helm BioLogics GmbH & Co. KG Competitive Strengths & Weaknesses
Table 143. RoosterBio, Inc Basic Information, Area Served and Competitors
Table 144. RoosterBio, Inc Major Business
Table 145. RoosterBio, Inc Cell Therapy and Tissue Engineering Product and Services
Table 146. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. RoosterBio, Inc Recent Developments/Updates
Table 148. RoosterBio, Inc Competitive Strengths & Weaknesses
Table 149. RoslinCT Basic Information, Area Served and Competitors
Table 150. RoslinCT Major Business
Table 151. RoslinCT Cell Therapy and Tissue Engineering Product and Services
Table 152. RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. RoslinCT Recent Developments/Updates
Table 154. RoslinCT Competitive Strengths & Weaknesses
Table 155. Rubius Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 156. Rubius Therapeutics, Inc. Major Business
Table 157. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 158. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Rubius Therapeutics, Inc. Recent Developments/Updates
Table 160. Rubius Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 161. Sangamo Therapeutics, Inc Basic Information, Area Served and Competitors
Table 162. Sangamo Therapeutics, Inc Major Business
Table 163. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
Table 164. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Sangamo Therapeutics, Inc Recent Developments/Updates
Table 166. Sangamo Therapeutics, Inc Competitive Strengths & Weaknesses
Table 167. Voyager Therapeutics, Inc Basic Information, Area Served and Competitors
Table 168. Voyager Therapeutics, Inc Major Business
Table 169. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product and Services
Table 170. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Voyager Therapeutics, Inc Recent Developments/Updates
Table 172. Voyager Therapeutics, Inc Competitive Strengths & Weaknesses
Table 173. Waisman Biomanufacturing Basic Information, Area Served and Competitors
Table 174. Waisman Biomanufacturing Major Business
Table 175. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product and Services
Table 176. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Waisman Biomanufacturing Recent Developments/Updates
Table 178. Waisman Biomanufacturing Competitive Strengths & Weaknesses
Table 179. WindMIL Therapeutics, Inc. Basic Information, Area Served and Competitors
Table 180. WindMIL Therapeutics, Inc. Major Business
Table 181. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 182. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. WindMIL Therapeutics, Inc. Recent Developments/Updates
Table 184. WindMIL Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 185. Wuxi App Tec, Inc. Basic Information, Area Served and Competitors
Table 186. Wuxi App Tec, Inc. Major Business
Table 187. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product and Services
Table 188. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Wuxi App Tec, Inc. Recent Developments/Updates
Table 190. Wuxi App Tec, Inc. Competitive Strengths & Weaknesses
Table 191. ReNeuron Group plc Basic Information, Area Served and Competitors
Table 192. ReNeuron Group plc Major Business
Table 193. ReNeuron Group plc Cell Therapy and Tissue Engineering Product and Services
Table 194. ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. ReNeuron Group plc Recent Developments/Updates
Table 196. ReNeuron Group plc Competitive Strengths & Weaknesses
Table 197. Richter-Helm BioLogics GmbH & Co. KG Basic Information, Area Served and Competitors
Table 198. Richter-Helm BioLogics GmbH & Co. KG Major Business
Table 199. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product and Services
Table 200. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. Richter-Helm BioLogics GmbH & Co. KG Recent Developments/Updates
Table 202. Richter-Helm BioLogics GmbH & Co. KG Competitive Strengths & Weaknesses
Table 203. RoosterBio, Inc Basic Information, Area Served and Competitors
Table 204. RoosterBio, IncMajor Business
Table 205. RoosterBio, Inc Cell Therapy and Tissue Engineering Product and Services
Table 206. RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. RoosterBio, Inc Recent Developments/Updates
Table 208. RoslinCT Basic Information, Area Served and Competitors
Table 209. RoslinCT Major Business
Table 210. RoslinCT Cell Therapy and Tissue Engineering Product and Services
Table 211. RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 212. Global Key Players of Cell Therapy and Tissue Engineering Upstream (Raw Materials)
Table 213. Cell Therapy and Tissue Engineering Typical Customers
List of Figure
Figure 1. Cell Therapy and Tissue Engineering Picture
Figure 2. World Cell Therapy and Tissue Engineering Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy and Tissue Engineering Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell Therapy and Tissue Engineering Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell Therapy and Tissue Engineering Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell Therapy and Tissue Engineering Revenue (2018-2029) & (USD Million)
Figure 13. Cell Therapy and Tissue Engineering Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell Therapy and Tissue Engineering Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell Therapy and Tissue Engineering Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy and Tissue Engineering by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy and Tissue Engineering Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy and Tissue Engineering Markets in 2022
Figure 27. United States VS China: Cell Therapy and Tissue Engineering Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy and Tissue Engineering Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell Therapy and Tissue Engineering Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell Therapy and Tissue Engineering Market Size Market Share by Type in 2022
Figure 31. Cell Therapy
Figure 32. Tissue Engineering
Figure 33. World Cell Therapy and Tissue Engineering Market Size Market Share by Type (2018-2029)
Figure 34. World Cell Therapy and Tissue Engineering Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Cell Therapy and Tissue Engineering Market Size Market Share by Application in 2022
Figure 36. Cell Defects
Figure 37. Genetic Diseases
Figure 38. Neurodegenerative Diseases
Figure 39. Tissue Malignancies
Figure 40. Others
Figure 41. Cell Therapy and Tissue Engineering Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Betalin Therapeutics BioCardia, Inc BioReliance Corporation Biosolution Co. Brainstorm Cell Therapeutics, Inc MaxCyte, Inc Medigene AG MEDIPOST CO. Mesoblast Limited Miromatrix Medical, Inc. MolMed S.p.A Mustang Bio, Inc NantKwest, Inc. Neuralstem, Inc NexImmune, Inc. Nohla Therapeutics, Inc ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT Rubius Therapeutics, Inc. Sangamo Therapeutics, Inc Voyager Therapeutics, Inc Waisman Biomanufacturing WindMIL Therapeutics, Inc. Wuxi App Tec, Inc. ReNeuron Group plc Richter-Helm BioLogics GmbH & Co. KG RoosterBio, Inc RoslinCT
Related Reports
11 Jan 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
